Cargando…

Cellular Reprogramming and Its Potential Application in Alzheimer’s Disease

Alzheimer’s disease (AD) has become the most common age-related dementia in the world and is currently incurable. Although many efforts have been made, the underlying mechanisms of AD remain unclear. Extracellular amyloid-beta deposition, intracellular tau hyperphosphorylation, neuronal death, glial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Chao, Ni, Wanyan, Zhu, Taiyang, Dong, Shuyu, Sun, Ping, Hua, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023048/ https://www.ncbi.nlm.nih.gov/pubmed/35464309 http://dx.doi.org/10.3389/fnins.2022.884667

Ejemplares similares

Potentials of Cellular Reprogramming as a Novel Strategy for Neuroregeneration
por: Fang, Lyujie, et al.
Publicado: (2018)

Corrigendum: Potentials of Cellular Reprogramming as a Novel Strategy for Neuroregeneration
por: Fang, Lyujie, et al.
Publicado: (2019)

Early activation of Toll-like receptor-3 reduces the pathological progression of Alzheimer’s disease in APP/PS1 mouse
por: Wang, Shang, et al.
Publicado: (2023)

Gain‐of‐function of progesterone receptor membrane component 2 ameliorates ischemic brain injury
por: Zhou, Chao, et al.
Publicado: (2023)

Reprogramming of Cellular Metabolism and Its Therapeutic Applications in Thyroid Cancer
por: Nagayama, Yuji, et al.
Publicado: (2022)

Comprehensive transcript-level analysis reveals transcriptional reprogramming during the progression of Alzheimer’s disease
por: Wu, Hao, et al.
Publicado: (2023)

Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy
por: Qi, Zhongbing, et al.
Publicado: (2022)

Single-nucleus transcriptional profiling uncovers the reprogrammed metabolism of astrocytes in Alzheimer’s disease
por: Fan, Li-Yuan, et al.
Publicado: (2023)

Aluminum and its potential contribution to Alzheimer's disease (AD)
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2014)

In vitro Methods to Cultivate Spiral Ganglion Cells, and Purification of Cellular Subtypes for Induced Neuronal Reprogramming
por: Meas, Steven J., et al.
Publicado: (2018)

Dityrosine cross-linking and its potential roles in Alzheimer’s disease
por: Maina, Mahmoud B., et al.
Publicado: (2023)

Clinical potential of angiogenic therapy and cellular reprogramming
por: Ryan, Christopher T., et al.
Publicado: (2021)

Manipulation of the nucleoscaffold potentiates cellular reprogramming kinetics
por: Yang, Benjamin A., et al.
Publicado: (2023)

MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic Biomarkers
por: Wei, Wei, et al.
Publicado: (2020)

Sox2 Level Is a Determinant of Cellular Reprogramming Potential
por: Han, Dong Wook, et al.
Publicado: (2013)

Application and prospects of somatic cell reprogramming technology for spinal cord injury treatment
por: Yang, Riyun, et al.
Publicado: (2022)

The cellular model for Alzheimer's disease research: PC12 cells
por: Xie, Danni, et al.
Publicado: (2023)

Application of CRISPR/Cas9 in Alzheimer’s Disease
por: Lu, Likui, et al.
Publicado: (2021)

Algorithm for cellular reprogramming
por: Ronquist, Scott, et al.
Publicado: (2017)

Updated Perspectives on Direct Vascular Cellular Reprogramming and Their Potential Applications in Tissue Engineered Vascular Grafts
por: Sellahewa, Saneth Gavishka, et al.
Publicado: (2022)

Application of Metabolomics in Alzheimer’s Disease
por: Wilkins, Jordan Maximillian, et al.
Publicado: (2018)

Systematic evaluation of urinary formic acid as a new potential biomarker for Alzheimer’s disease
por: Wang, Yifan, et al.
Publicado: (2022)

The Chromatin Environment Around Interneuron Genes in Oligodendrocyte Precursor Cells and Their Potential for Interneuron Reprograming
por: Boshans, Linda L., et al.
Publicado: (2019)

Trajectories of the Hippocampal Subfields Atrophy in the Alzheimer’s Disease: A Structural Imaging Study
por: Zhao, Weina, et al.
Publicado: (2019)

Metabolic reprogramming by KSHV in cellular transformation
por: Zhu, Ying, et al.
Publicado: (2014)

DNA Demethylation Upregulated Nrf2 Expression in Alzheimer’s Disease Cellular Model
por: Cao, Huimin, et al.
Publicado: (2016)

Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease
por: Knight, Michael J., et al.
Publicado: (2016)

Boldine Attenuates Synaptic Failure and Mitochondrial Deregulation in Cellular Models of Alzheimer’s Disease
por: Toledo, Juan P., et al.
Publicado: (2021)

Dissecting the Potential Roles of Nigella sativa and Its Constituent Thymoquinone on the Prevention and on the Progression of Alzheimer's Disease
por: Cascella, Marco, et al.
Publicado: (2018)

In vitro cellular reprogramming to model gonad development and its disorders
por: Gonen, Nitzan, et al.
Publicado: (2023)

Circulating extracellular vesicle-containing microRNAs reveal potential pathogenesis of Alzheimer’s disease
por: Wang, Yi, et al.
Publicado: (2022)

Potential Utility of Retinal Imaging for Alzheimer’s Disease: A Review
por: Liao, Huan, et al.
Publicado: (2018)

Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?
por: Qiu, Wei Qiao, et al.
Publicado: (2014)

Potential Diagnostic Applications of Multi-Delay Arterial Spin Labeling in Early Alzheimer’s Disease: The Chinese Imaging, Biomarkers, and Lifestyle Study
por: Sun, Mengfan, et al.
Publicado: (2022)

Transcriptional reprogramming in cellular quiescence
por: Roche, Benjamin, et al.
Publicado: (2017)

Cellular reprogramming and epigenetic rejuvenation
por: Simpson, Daniel J., et al.
Publicado: (2021)

Low-Rank Plus Sparse Decomposition of fMRI Data With Application to Alzheimer's Disease
por: Tu, Wei, et al.
Publicado: (2022)

Direct Reprogramming Rather than iPSC-Based Reprogramming Maintains Aging Hallmarks in Human Motor Neurons
por: Tang, Yu, et al.
Publicado: (2017)

Epigenetics in Alzheimer’s Disease
por: Gao, Xiaodie, et al.
Publicado: (2022)

Our “energy-Ca(2+) signaling deficits” hypothesis and its explanatory potential for key features of Alzheimer’s disease
por: Chen, Ming, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7pf18do8nn1ogd3kc88fqbsg4f